Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arora, Deepa
NCT05478486: Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours	Not yet recruiting	1	27	RoW	MSP008-22	Godavari Biorefineries Limited	Advanced Solid Tumor	12/22	01/23
NCT05532293: Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers	Not yet recruiting	1	72	RoW	MSP008-22, Placebo	Godavari Biorefineries Limited	COVID-19	01/23	04/23
Kshirsagar, Srinath
NCT05532293: Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers	Not yet recruiting	1	72	RoW	MSP008-22, Placebo	Godavari Biorefineries Limited	COVID-19	01/23	04/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arora, Deepa
NCT05478486: Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours	Not yet recruiting	1	27	RoW	MSP008-22	Godavari Biorefineries Limited	Advanced Solid Tumor	12/22	01/23
NCT05532293: Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers	Not yet recruiting	1	72	RoW	MSP008-22, Placebo	Godavari Biorefineries Limited	COVID-19	01/23	04/23
Kshirsagar, Srinath
NCT05532293: Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers	Not yet recruiting	1	72	RoW	MSP008-22, Placebo	Godavari Biorefineries Limited	COVID-19	01/23	04/23